Celgene identifies CELMoD compounds for treating relapsed and refractory multiple myeloma Aug. 29, 2019
Discovery and preclinical identification of novel mutant EGFR allosteric inhibitor JBJ-04-125-02 Aug. 29, 2019
Phase III results for V-212 inactivated varicella zoster virus vaccine in patients with malignancies Aug. 29, 2019